Your session is about to expire
← Back to Search
Mercaptopurine Compliance for Leukemia
Study Summary
This trial is testing a new way to help patients with leukemia take their medication, to see if it improves treatment outcomes.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2021 Phase 3 trial • 3154 Patients • NCT00075725Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You have Down syndrome.I have ALL and am in my first remission.I have completed 24 weeks of ongoing cancer treatment and will continue for at least another 24 weeks.I am taking 6MP for ALL and will visit the clinic every 4 weeks as part of COG ACCL1033.I, and my caregiver if applicable, can communicate in English or Spanish.
- Group 1: Arm II (standard of care and mercaptopurine)
- Group 2: Arm I (intervention program and mercaptopurine)
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Pivotal Trial - The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Does Mercaptopurine have a history of being studied in clinical trials?
"The first study of mercaptopurine happened in 2002 at Manitoba Blood & Marrow Transplant Program CancerCare Manitoba. To date, there have been 776 completed clinical trials. Right now, there are 45 active clinical trials, a significant number of which are taking place in San Antonio, Texas."
Has Mercaptopurine undergone Food and Drug Administration approval?
"Mercaptopurine is estimated to be a safe drug, as it has gone through multiple rounds of testing with Phase 3 trials."
Could you please tell me how many different locations this trial is running in?
"You can find a list of the 100 active clinical sites for this trial on the website. They are located all over, including in San Antonio, Royal Oak and Pittsburgh, to name a few. If you decide to enroll, you should pick a location that is close to you to cut down on travel."
Is this research currently recruiting participants?
"This specific trial is not looking for any more patients at the moment, however that doesn't mean other trials aren't. According to the latest information on clinicaltrials.gov, this trial was last edited on 6/8/2022 and 1586 other trials are still open."
Are participants in this study required to be a certain age?
"If you meet the age requirements of 1-21 years old, then you may be eligible to participate in this clinical trial."
How many people are total are participating in this trial?
"This study has reached its patient quota and is no longer recruiting. The trial was initially posted on February 21st, 2012 and was edited for the last time on June 8th, 2022. If you are looking for other trials, there are currently 1541 trials for leukemia and 45 trials for Mercaptopurine that are still enrolling patients."
Share this study with friends
Copy Link
Messenger